University of Rochester researchers developed a noninvasive bioluminescent optogenetics technique to activate brain neurons for Parkinson's treatment, reducing device-related infection risks.

Researchers at the University of Rochester have introduced a noninvasive technique called bioluminescent optogenetics (BL-OG) that activates brain neurons using light derived from a substance called luciferin, similar to fireflies. This method offers a safer alternative to traditional deep brain stimulation for treating conditions like Parkinson's disease by eliminating the need for implanted devices, thus reducing infection risks. The research was supported by the Alfred P. Sloan Foundation.

October 03, 2024
3 Articles